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Abstract
The 1555 A to G substitution in mitochondrial 12S A-site rRNA is
associated with maternally transmitted deafness of variable pene-
trance in the absence of otherwise overt disease. Here, we recapit-
ulate the suggested A1555G-mediated pathomechanism in an
experimental model of mitoribosomal mistranslation by directed
mutagenesis of mitoribosomal protein MRPS5. We first establish
that the ratio of cysteine/methionine incorporation and read-
through of mtDNA-encoded MT-CO1 protein constitute reliable
measures of mitoribosomal misreading. Next, we demonstrate that
human HEK293 cells expressing mutant V336Y MRPS5 show
increased mitoribosomal mistranslation. As for immortalized
lymphocytes of individuals with the pathogenic A1555G mutation,
we find little changes in the transcriptome of mutant V336Y MRPS5
HEK cells, except for a coordinated upregulation of transcripts for
cytoplasmic ribosomal proteins. Homozygous knock-in mutant
Mrps5 V338Y mice show impaired mitochondrial function and a
phenotype composed of enhanced susceptibility to noise-induced
hearing damage and anxiety-related behavioral alterations. The
experimental data in V338Y mutant mice point to a key role of
mitochondrial translation and function in stress-related behavioral
and physiological adaptations.
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Introduction
Mitochondria are multi-functional organelles involved in oxidative
metabolism, cellular homeostasis, and signal transduction. They are
the primary energy-providing system in eukaryotic cells by accom-
modating the enzymatic machinery of oxidative phosphorylation for
ATP production. The mitochondrial oxidative phosphorylation
system is made up of more than 100 different proteins, 13 of which
are encoded by mitochondrial DNA and all the others by nuclear
genes [1]. Mitochondrial DNA is maternally inherited, and the
human mtDNA encodes in addition to the 13 proteins of the respira-
tory electron transport chain (ETC) for 22 tRNA and two ribosomal
RNA genes required for their translation [2,3].
Mitochondria are of endosymbiotic origin [4], and the mitochon-
drial ribosomes are more closely related to bacterial ribosomes than
to eukaryotic cytosolic ribosomes [5]. Mitochondrial protein synthe-
sis allows for the translation of the 13 respiratory subunits encoded
by the mitochondrial genome [6]. All of the more than 1,000 other
proteins of the mammalian mitochondrial proteome are synthesized
by the cytosolic ribosome [7–10].
Classical mitochondrial diseases result from mutations in mtDNA
or nuclear genes that disrupt mitochondrial function [11,12]. Back
in 1993, a pivotal study established that the nucleotide 1555 A to G
substitution in the mitochondrial 12S rRNA gene predisposes to
maternally transmitted, non-syndromic sensorineural deafness [13].
The A1555G mutation produces a clinical phenotype that may range
from normal hearing to progressive hearing loss or severe congeni-
tal deafness [14]. Early biochemical investigations of the A1555G
mutation using transmitochondrial cell lines pointed to a role for
mitochondrial protein synthesis [15], but the molecular mechanisms
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involved remained obscure [16–18]. In the absence of experimental
models of mtDNA manipulation, we have previously used bacterial
genetics to reconstruct the corresponding rRNA substitution in
bacterial ribosomes. These studies suggested that the pathogenic
A1555G mutation affects ribosomal accuracy [19]. The postulated
mechanism, however, was difficult to reconcile with the significant
and diverse pathologies associated with mutations in nuclear-
encoded mitochondrial aminoacyl-tRNA synthetases [20–22] and
the apparent absence of A1555G-associated disease in non-cochlear
tissues. Here, to address this question, we mutated the nuclear-
encoded mitochondrial ribosomal protein MRPS5 to result in an
experimental model of mitoribosomal mistranslation.
Results
Identification of a potentially misreading mutation in
mitoribosomal protein MRPS5 and in homologous bacterial
ribosomal protein RpsE
The amino acid replacement S200Y in yeast cytosolic ribosomal
protein Rps2 (uS5) is a ribosomal ambiguity mutation (ram) that
confers misreading in yeast cytosolic ribosomes [23]. We modeled
the corresponding amino acid replacement on available crystal
structures of the homologous mitochondrial protein MRPS5 (uS5m)
and homologous bacterial protein RpsE (uS5) [24,25]. Modeling
indicates that replacement of the corresponding native amino acid
with the large aromatic tyrosine residue in both mitochondrial
MRPS5 (human MRPS5 V336Y) and bacterial RpsE (Escherichia coli
rpsE A127Y) would result in steric hindrance within the protein C-
terminal domain, similar to what is observed for S200Y in the yeast
Rps2 protein (Appendix Fig S1).
RpsE A127Y is a misreading mutation in bacterial ribosomes
To study whether the mutation rpsE A127Y is a ram mutation in
bacterial ribosomes, we generated bacterial mutants by introducing
the corresponding mutation into E. coli (rpsE A127Y) and Mycobac-
terium smegmatis (rpsE S152Y) (Appendix Fig S1). We determined
ribosomal misreading and read-through in cell-free translation
assays using dual luciferase gain-of-function reporters. In addition,
we included bacterial mitohybrid ribosomes with and without the
pathogenic A1555G mutation in the analysis. Reconstructions of
mitochondrial 12S rRNA in bacterial ribosomes, with the bacterial
decoding A-site in rRNA helix 44 replaced by the corresponding
mitochondrial sequence, have established that the A1555G mutation
affects translation accuracy [19]. E. coli rpsE A127Y, M. smegmatis
rpsE S152Y, and bacterial mitohybrid ribosomes with the pathogenic
A1555G mutation all showed significantly increased levels of
misreading of near-cognate codons and read-through in comparison
with their respective controls (Fig 1A and B).
Ratio of cysteine/methionine incorporation and increased read-
through upon translation of MT-CO1 mRNA are markers for
ribosomal misreading
Mitochondrial ribosomes are neither suitable for cell-free translation
assays, nor is it technically feasible to introduce reporter genes to
probe mitoribosomal accuracy, given the current limitations in
genetic manipulation of mitochondria of higher eukaryotes [26].
Amino acid sequence analysis of the 13 mtDNA-encoded human
proteins (NCBI, JO1415.2) revealed that the mitochondrial cyto-
chrome oxidase subunit I MT-CO1 (COX1) protein contains a single
cysteine and 32 methionines. Additionally, the nucleic acid sequence
encoding MT-CO1 shows 96 near-cognate codons for cysteine and 48
near-cognate codons for methionine. This yields a ratio of near-
cognate/cognate codons for cysteine versus near-cognate/cognate
codons for methionine of 64.0 [(96/1)/(48/32); for calculation of
cognate and near-cognate frequencies, see Appendix Table S1].
Based on these calculations, we hypothesized that misreading would
increase the ratio of cysteine/methionine incorporation and decided
to assess ribosomal accuracy by determining the amount of cysteine
versus methionine incorporation in MT-CO1 protein.
We used bacterial A1555G mutant and wild-type mitohybrid
ribosomes to demonstrate that experimental determination of
cysteine/methionine incorporation in MT-CO1 can be used to assess
misreading. The MT-CO1 sequence adapted to bacterial codon usage
resulted in a change in the near-cognate/cognate codon ratio for
cysteine versus methionine to 86.7 [(130/1)/(48/32); the ratio is dif-
ferent from the mitochondrial ratio because bacteria have fewer
near-cognate methionine codons]. The ratio of cysteine/methionine
incorporated upon in vitro translation of MT-CO1 mRNA was signifi-
cantly increased in the mutant A1555G mitohybrid ribosomes as
compared to wild-type mitohybrid ribosomes (Fig 1C). Further
support for this observation was provided by the finding that treat-
ment with the aminoglycoside tobramycin increased misreading in a
similar manner when assessing MT-CO1 cysteine/methionine incor-
poration or when using a luciferase gain-of-function assay, for both
A1555G mitohybrid ribosomes and wild-type mitohybrid ribosomes
(Fig 1D and E; note that the pathogenic A1555G mutation confers
hypersusceptibility to tobramycin-induced misreading [19]).
The hungry AGA codon at the 30 end of the MT-CO1 protein
results in a 1 frameshift on the ribosome, allowing a UAG stop
codon to be recognized by mitochondrial release factor mtRF1a
[27]. We hypothesized that misreading mitochondrial ribosomes
should bypass the MT-CO1 stop signal by read-through, resulting in
an extended protein with a C-terminal poly-lysine stretch (no stop
codon is present in the MT-CO1 30 UTR in-frame or in 1 frame,
facilitating translation of the polyA tail). We first validated this
assay using bacterial A1555G mitohybrid ribosomes because of their
hypersusceptibility to aminoglycosides [19]. Using the MT-CO1
sequence adapted to bacterial codon usage, two synthetic mRNAs
were generated—one MT-CO1 mRNA with the native AGA codon
(MT-CO1 AGA, AGA encoding arginine in bacterial translation) and
a second MT-CO1 mRNA with the AGA codon replaced by a UGA
stop codon (MT-CO1 TGA). Both constructs carry the 30 UTR of MT-
CO1 (69 nt) followed by a polyA tail of 51 nucleotides. In the
absence of aminoglycosides, A1555G hybrid ribosomes produced a
57.1 kD-sized protein corresponding to the native MT-CO1 protein
when translating MT-CO1 UGA mRNA and an extended MT-CO1
62.1 kD-sized protein when translating MT-CO1 AGA mRNA
(Fig 1F). Two effects were observed in the presence of increasing
amounts of aminoglycoside. First, protein synthesis became inhib-
ited due to the inhibitory effect of tobramycin on ribosomal translo-
cation. Second, increasing amounts of the extended 62.1 kD
MT-CO1 protein were produced for the MT-CO1 UGA mRNA due to
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Figure 1. Determination of translational accuracy in cell-free translation assays.
A, B Misreading (A) and read-through (B) were measured by dual luciferase gain-of-function assays using wild-type mitohybrid ribosomes (n = 8 misreading, n = 4
read-through), mutant A1555G mitohybrid ribosomes (n = 8 misreading, n = 4 read-through), E. coli wild-type ribosomes (n = 9), E. coli mutant A127Y ribosomes
(n = 9), M. smegmatis merodiploid wild-type ribosomes (n = 9), and M. smegmatis merodiploid mutant S152Y ribosomes (n = 9). Mistranslation was determined by
assessing the misreading at His245 (CAC codon) of the F-luc gene that was replaced by the near-cognate codon CGC or the non-cognate codon AGA, both encoding
for Arg. To determine read-through, the Asp357 (GAC codon) of the F-luc gene was replaced by the nonsense TGA stop codon. Results are derived by calculating
mutant hFluc/hRluc activity related to wild-type hFluc/hRluc activity. Wild-type samples were set as 1, error bars indicate SEM; **P < 0.01, ***P < 0.005,
****P < 0.001, ns, not significant (Student’s t-test).
C Ratio of 35S-cysteine/35S-methionine incorporation by in vitro translation using wild-type mitohybrid ribosomes, mutant A1555G mitohybrid ribosomes, and MT-CO1
mRNA. Following immunoprecipitation, the MT-CO1 band was quantified by autoradiography, and wild-type mitohybrid ribosomes were set as 1 (n = 3), error bars
indicate SEM; ****P < 0.001 (Student’s t-test). Products of immunoprecipitation as resolved by SDS–PAGE are shown exemplarily in Appendix Fig S2E.
D Ratio of 35S-cysteine/35S-methionine incorporation by in vitro translation in the presence of tobramycin using wild-type mitohybrid ribosomes, mutant A1555G
mitohybrid ribosomes, and MT-CO1 mRNA; the MT-CO1 band was quantified by autoradiography.
E Misreading of wild-type mitohybrid ribosomes and mutant A1555G mitohybrid ribosomes in the presence of tobramycin. Misreading was assessed by dual
luciferase assay, and results derived by calculating mutant hFluc/hRluc activity are related to wild-type hFluc/hRluc activity.
F In vitro translation of MT-CO1-TGA mRNA and MT-CO1-AGA mRNA using mutant A1555G mitohybrid ribosomes in the presence of tobramycin (0–20 lM).
Autoradiography of immunoprecipitated MT-CO1 proteins; top: 35S-Met labeling, bottom: 14C-Lys labeling. In organello-translated 35S-Met-labeled MT-CO1 was
used as a marker. * MT-CO1, ** MT-CO1 extended by read-through; MT-CO1 AGA-polyA and MT-CO1 TGA-polyA constructs used for in vitro translation are
schematized.
G Ratio of 14C-Lys/35S-Met-labeled immunoprecipitated MT-CO1 proteins. In vitro translation using MT-CO1-TGA mRNA, MT-CO1-AGA mRNA, and mutant A1555G
mitohybrid ribosomes in the presence of tobramycin (0–20 lM). The corresponding MT-CO1 band was quantified by autoradiography.
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tobramycin-induced UGA stop codon read-through, 30 UTR transla-
tion, and synthesis of a poly-lysine stretch (Fig 1F). In further
support of our conclusion, in vitro translation in the presence of
14C-lysine showed that the ratio of 14C-lysine/35S-methionine incor-
poration increased in the presence of tobramycin (Fig 1G), as
expected when aminoglycoside-induced read-through results in the
synthesis of a poly-lysine stretch. No extended MT-CO1 protein was
synthesized in the presence of tobramycin upon translation of MT-
CO1 mRNA with a TAA stop codon lacking 30 UTR and polyA tail
(Appendix Fig S2A).
Collectively, these data demonstrate that both the ratio of
cysteine/methionine incorporation and the increased read-through
upon translation of MT-CO1 mRNA constitute valid markers for
ribosomal misreading.
Mutation V336Y in MRPS5 confers mitoribosomal misreading in in
organello translation
We next generated stably transfected human HEK cells of mutant
V336Y MRPS5 and wild-type MRPS5 controls. We found evidence
that the transgene-encoded MRPS5 protein localizes to the mito-
chondrial fraction using myc-tagged MRPS5 (Appendix Fig S2B).
A GFP reporter was added downstream of MRPS5 via an internal
ribosomal entry site (IRES) to facilitate monitoring of transgene
expression. V336Y mutants and wild-type control transfectants
showed similar GFP fluorescence (Appendix Fig S2C). We quanti-
fied MRPS5 mRNA expression by RT–qPCR to demonstrate that
transfected V336Y mutant MRPS5 and transfected wild-type MRPS5
produce similar levels of MRPS5 mRNA (Appendix Fig S2D).
To investigate the accuracy of mitochondrial translation, we used
in organello translation and determined the ratio of cysteine/
methionine incorporation in MT-CO1 protein. In organello transla-
tion in the presence of the misreading agent tobramycin resulted in
a significantly increased ratio of cysteine/methionine incorporation
in MT-CO1 protein (Fig 2A). Compared to MT-CO1 with a ratio of
64.0 for near-cognate/cognate codons for cysteine versus methion-
ine, this ratio is only 3.8 for the mtDNA-encoded cytochrome
oxidase subunit 2 MT-CO2 (near-cognate/cognate codons for
cysteine versus near-cognate/cognate codons for methionine: 29/3
versus 26/10, see Appendix Table S1). We thus predicted that
compared to MT-CO1, in organello translation in the presence of the
misreading agent tobramycin should not grossly affect the ratio of
cysteine/methionine incorporation in MT-CO2. As shown in Fig 2B,
treatment with tobramycin resulted in a dose-dependent increase in
A B C D E
Figure 2. Assessment of mitoribosomal misreading in in organello translation.
A Autoradiography of in organello mitochondrial translation products derived from HEK293 wild-type cells in the presence of tobramycin, incorporation of 35S-Met and
35S-Cys in MT-CO1 protein. Following in organello translation proteins were immunoprecipitated and analyzed by autoradiography. Lane 1, 3: controls; lanes 2, 4: in
organello translation in the presence of 1,000 lM tobramycin. MT-CO1 bands were quantified and ratio of 35S-Cys/35S-Met calculated, and the 35S-Cys/35S-Met ratio in
the absence of tobramycin was set as 1 (n = 3), error bars indicate SEM.
B Ratio of 35S-Cys/35S-Met-labeled MT-CO1 and MT-CO2 proteins synthesized in in organello translation and effect of tobramycin. Following in organello translation in
the presence of tobramycin (1,000 lM, 2,000 lM), proteins were immunoprecipitated and analyzed by autoradiography. MT-CO1 and MT-CO2 bands were
quantified, and ratio of 35S-Cys/35S-Met incorporation was calculated (n = 3), error bars indicate SEM; *P < 0.05 (Student’s t-test), ns, not significant.
C Ratio of 35S-Cys/35S-Met-labeled MT-CO1 protein synthesized in in organello translation using mitochondria from HEK293 MRPS5 wild-type cells and HEK MRPS5
mutant V336Y cells. Following in organello translation, proteins were immunoprecipitated and analyzed by autoradiography. MT-CO1 bands quantified and ratios
calculated. The ratio of the MRPS5 wild-type was set as 1 (n = 8 clones), error bars indicate SD; ***P < 0.0001 (Student’s t-test).
D Autoradiography of in organello mitochondrial translation products derived from HEK293 MRPS5 wild-type cells in the presence of tobramycin (0–750 lM). Proteins
were 35S-Met-labeled and loaded either directly on SDS–PAGE (total, top) or following poly-lysine immunoprecipitation (bottom). * MT-CO1 and ** MT-CO1 with poly-
lysine extension.
E Quantification of MT-CO1 proteins in HEK293 MRPS5 wild-type cells and HEK293 MRPS5 mutant V336Y cells. In organello mitochondrial translation in the presence of
35S-Met and 750 lM tobramycin. Proteins were loaded either directly on SDS–PAGE (total) or following poly-lysine immunoprecipitation and analyzed by
autoradiography. For total protein samples, the MT-CO1 band was quantified, for poly-lysine immunoprecipitated samples, the extended MT-CO1 band was
quantified and the ratio of extended MT-CO1/total MT-CO1 was calculated. The ratio of MRPS5 wild-type was set as 1 (MRPS5 wild-type, n = 5 clones, MRPS5 V336Y,
n = 7 clones), error bars indicate SD; ***P < 0.0001 (Student’s t-test).
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the ratio of cysteine/methionine incorporation in MT-CO1 protein,
but did not measurably affect this ratio in MT-CO2 protein. We next
studied the ratio of cysteine/methionine incorporation in MT-CO1
protein in mutant V336Y MRPS5 and wild-type control transfectants.
In comparison with the wild-type control mutant, V336Y MRPS5
transfectants showed a significantly increased ratio of cysteine/
methionine incorporation in MT-CO1 protein (Fig 2C).
Immunoprecipitation with anti-lysine antibodies was used to
study read-through of MT-CO1 in mitochondrial in organello transla-
tion. In the presence of increasing tobramycin concentrations,
increasing amounts of extended MT-CO1 protein were produced
(Fig 2D). Compared to wild-type MRPS5 transfected cells, mitochon-
drial extracts from mutant V336Y cells showed significantly
increased read-through of the MT-CO1 protein (Fig 2E).
Together, and consistent with our modeling predictions, these
findings demonstrate that the MRPS5 V336Y mutation confers
mitoribosomal misreading.
Effects of MRPS5 V336Y-mediated mitoribosomal misreading in
HEK293 cells
Measurements of ATP levels, mitochondrial mass, mtDNA/nuclear
DNA ratio, and oxygen consumption showed no significant dif-
ferences between wild-type MRPS5-transfected and mutant V336Y
MRPS5-transfected cells (Appendix Fig S3A–D). Measurements of
generation time and quantitative (35S-Met incorporation) and qual-
itative (SDS–PAGE of 35S-Met-labeled proteins) assessments of
mitochondrial translation (Fig 3A–C) also showed no differences.
We corroborated the finding that generation time and protein
synthesis efficacy were unaffected by using the corresponding
mutation in the bacterial system (E. coli—rpsE A127Y, M. smeg-
matis—rspE S152Y; see Appendix Fig S3E and F). These data indi-
cate that, despite conferring misreading, the homologous
mutations in ribosomal proteins MRPS5 and rpsE do not grossly
affect efficiency of protein synthesis in phylogenetically related
translation systems. Together, these data demonstrate that the
mitoribosomal misreading mutation MRPS5 V336Y little affects
HEK293 cells.
In comparison with wild-type MRPS5-transfected cells, transcrip-
tomic analysis of the V336Y mutants by RNA sequencing revealed
little differences, except for an overexpression of cytoplasmic ribo-
somal proteins. The top five affected GO terms were all cytoplasmic
ribosome-related (GO term ribosome, adjusted P-value 2.46 × 104;
see Fig 3D).
Mutation V338Y in MRPS5 affects ETC function in brain cells
in vivo
Next, we constructed homozygous knock-in mutant Mrps5 mice
(Mrps5V338Y/V338Y; in mice, the homologous position in Mrps5 is
V338Y, see Appendix Fig S1) using a FLEx strategy; for further
details, see Materials and Methods and Appendix Fig S4. Mutant
Mrps5 V338Y mice are viable, born at the expected frequencies,
have normal physical appearance, and show no overt signs of
disease.
We evaluated the capacity of the oxidative phosphorylation
system in brain cortical mitochondria of both mature (9-month-old)
and aged (19-month-old) Mrps5V338Y/V338Y and wild-type control
mice using the Seahorse XF24 flux analyzer system (Fig 4A–D).
Total oxygen consumption rate (OCR) was significantly reduced in
the mitochondria of 9- and 19-month-old Mrps5 V338Y mice
compared to mitochondria of age-matched wild-type mice. Specifi-
cally, basal activity (state 2) and maximal respiration (state 3, which
measures the capacity of mitochondria to metabolize oxygen in the
presence of the ATP synthase substrate ADP) showed an age- and
mutation-related decline (Fig 4B and C). In addition, respiration in
the absence of a proton gradient (uncoupled state 3u following
injection of FCCP) was significantly impaired in the mutant mice
(Fig 4D).
Deterioration of mitochondrial function is often related to an age-
dependent decrease of ATP and increased levels of ROS as a result
of ETC leakage, prompting us to examine ATP and ROS levels in the
mitochondria of 19-month-old animals, in addition to measurements
of complex II and complex IV activities. In contrast to complex II
which is exclusively encoded by nuclear genes, complex IV is
encoded by both nuclear and mitochondrial genes. Thus, comparing
complex IV activity to that of complex II (complex IV/complex II
ratio) highlights the impact of the Mrps5 V338Y mutation.
A B
C D
Figure 3. Analysis of HEK293 mutant MRPS5 V336Y and HEK293 MRPS5
wild-type cells.
A Generation time (n = 8 clones,  SD).
B Whole cell in vivo mitochondrial translation as determined by 35S-Met
incorporation (n = 4 clones,  SEM).
C Autoradiography of in organello translation using 35S-Met labeling.
D Top five GO terms (cellular component) associated with genes upregulated
in HEK293 mutant MRPS5 V336Y compared to HEK293 wild-type MRPS5.
Corresponding GO terms associated with genes upregulated in mutant MT-
RNR1 A1555G lymphocytes (Hollis et al, 2015) were plotted for comparison.
The bars represent the percentage of genes that map to a GO term and
which are upregulated. Fisher’s exact t-test, +P < 106, ++P < 107,
+++P < 108 (MRPS5 V336Y n = 4, MRPS5 wild-type n = 6); *P < 1030,
**P < 1040, ***P < 1050 (A1555G n = 28, wild-type n = 15).
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Compared to wild-type control mice, the complex IV/complex II
ratio was significantly reduced in cortical mitochondria from mutant
mice (Fig 4E). Consistent with the finding of a mutation-related
decline in coupling efficiency of ETC, we observed reduced ATP
levels and increased amounts of mitochondrial reactive oxygen
species (mtROS) in mitochondria of Mrps5V338Y/V338Y mice (Fig 4F
and G).
Mutant MRPS5 mice show age-related and stress-induced
behavioral alterations
Mutant Mrps5V338Y/V338Y mice and littermates did not present any
overt difference in spontaneous behavior. To assess a large spec-
trum of more subtle behavioral phenotypes, we subjected
Mrps5V338Y/V338Y mice and their littermates to a comprehensive
battery of tests for changes in learning and memory, species-typical
behavior, anxiety, exploration, and sensorimotor function. We stud-
ied mice at the age of 9 and 19 months to detect early-onset and
age-related phenotypes; selected tests were also recorded at
14 months of age.
Locomotor activities in the home cage, in the large open field,
during light–dark transition, and in the elevated O-maze were
affected neither by genotype nor by age (Appendix Fig S5A–D).
Swim speed in the water-maze, performance on the rotarod, grip
test, hot plate test, and acoustic startle (Appendix Fig S5E–H) did
not show any mutational effect on sensorimotor function.
Responses in the acoustic startle were reduced in 19-month-old
mice, most likely due to the age-related hearing loss typically seen
in C57BL/6 mice [28].
To evaluate anxiety-related and exploratory behavior, we tested
mice in the large open field, light–dark transition, elevated O-
maze, and IntelliCage. In the large open field, littermate controls
showed an age-dependent increase in center avoidance and a
decrease in rearing activity from 9 to 19 months of age. In
contrast, Mrps5V338Y/V338Y animals showed pronounced center
avoidance and low rearing activity at all ages, with 9-month-old
Mrps5V338Y/V338Y mice already resembling aged animals (Fig 5A
and B). Area explored in the large open field (Appendix Fig S5I)
and avoidance of the brightly illuminated chamber in the light–
dark transition test (Fig 5C) showed similar age dependency, with
Mrps5V338Y/V338Y being less explorative than controls at the age of
9 months but not at the age of 19 months. On the elevated O-
maze, responses of Mrps5V338Y/V338Y animals were statistically
indistinguishable from those of controls even though on average
they spent slightly less time in the open arms (Appendix Fig S5J).
Explorative analysis of individual cohorts during the free
adaptation stage in IntelliCage revealed decreased activity for
Mrps5V338Y/V338Y mice at 9 months of age (Fig 5D).
Learning and memory were evaluated in the T-maze sponta-
neous alternation test and the IntelliCage and compared to perfor-
mance in the more adverse environment of the water-maze place
and cue navigation tasks. Performance in the T-maze spontaneous
alternation test (Appendix Fig S5K), and learning in the serial rever-
sal (Fig 5E) and chaining (Fig 5F) tasks in IntelliCage were not
affected by genotype. In the water-maze place navigation task, the
performance during acquisition and reversal training worsened
significantly in the controls with aging. In contrast, Mrps5V338Y/V338Y
mice performed poorly already at young age and were significantly
impaired compared to the controls at 9 months of age (Fig 5G). The
poor escape of the Mrps5 mutants in the place navigation task was
accompanied by an increased number of wall approaches, again




Figure 4. Mutation-related mitochondrial function in brain.
A–D Oxygen consumption rate (OCR) was measured in freshly isolated
mitochondria from wild-type and mutant mouse cortex. (A) OCR in brain
mitochondria from 19-month-old mutant mice (black circle) compared
with OCR from wild-type mice (white circle). The sequential injection of
mitochondrial substrates and inhibitors is indicated by dotted lines (see
details in the Materials and Methods section). Values corresponding to
the different respiratory states are shown. (B) Baseline OCR, effect of age
(P < 0.0001), and genotype (P < 0.05). (C) State 3 OCR (after addition of
ADP), effect of age (P < 0.001), and genotype (P < 0.0001). (D) State 3
uncoupled OCR (state 3u after addition of FCCP), effect of genotype
(P < 0.0001), and age–genotype interaction (P < 0.0001).
E Ratio of mitochondrial complex IV/complex II activities.
F ATP levels.
G Superoxide anion radicals.
Data information: Panels (A–D) are represented as mean  SEM (n = 10–12
replicates of five to six animals per group); *P < 0.05, ***P < 0.0001 (wild-type
versus mutant); +++P < 0.0001 (19 months versus 9 months); post hoc test
followed by two-way ANOVA significance test. Panels (E–G) are represented as
mean  SD (n = 5–6); **P < 0.001, ***P < 0.0001 (wild-type versus mutant)
(Student’s t-test).
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animals (Fig 5H). In the probe trial (Fig 5I), Mrps5 mutants showed
overall significantly reduced preference for the trained target zone.
Consistent with an age-dependent phenotype of the mutation, a
significant zone × genotype interaction was observed for the 9- and
14-month-old cohorts, but not for the 19-month-old animals. The
cue navigation protocol in the water-maze showed a small overall
deficit in Mrps5 mutant mice (Appendix Fig S5L).
From the above results, we conclude that mutation effects on
learning task performance were strongly context-dependent. While
we observed no adverse mutation effect or age-related perfor-
mance declines in T-maze alteration and IntelliCage learning,
performance in the water-maze place navigation task was strongly
affected by the mutation in an age-dependent manner. As the
performance of the mutants was only affected in the water-maze
and not in other learning tasks, it is unlikely that this deficit is
reflective of a genuine cognitive impairment, also supported by the
finding that hippocampus-dependent burrowing and nesting were
unaffected by the mutation (Appendix Fig S5M and N). Rather, as
also supported by the results of our tests on anxiety and explo-
ration, water-maze performance was probably disrupted by an
excessive sensitivity of Mrps5 mutants to the aversive stress condi-
tions associated with this test. In less aversive environments such
as the T-maze or IntelliCage, Mrps5 mutants were able to learn
normally.
Comparative brain histopathological analyses of 9-month-old
Mrps5V338Y/V338Y mice and age-matched wild-type controls did not
reveal any difference. In particular, no signs of neurodegeneration
were found in the mutant mice.
Mutation V338Y heightens susceptibility to noise-related
auditory damage
We selected auditory function in vivo as a sensory modality suscep-
tible to environmental stress on mitochondria [29]. The non-inva-
sive procedure of auditory brain stem responses (ABR) records
neuronal activity along the auditory pathways and provides infor-
mation on the functional integrity of the cochlea. Mrps5V338Y/V338Y
and control mice had comparable baseline thresholds of around








B C ◀ Figure 5. Exploration and anxiety, home cage learning, and placelearning in the water-maze.
A Average distance to center as measure of anxiety in the open field (ANOVA:
genotype F1,24 = 16.24, P = 0.0005, age F2,24 = 5.217, P = 0.0131). Mutants
show increased anxiety levels at 9 and 14 months.
B Estimated frequency of rearing activity as measure of exploratory drive in
the open field (ANOVA: genotype F1,24 = 39.40, P < 0.0001, age × genotype
F2,26 = 8.204, P = 0.0017). Mutants showed little exploratory activity at 9
and 14 months.
C Light–dark transition test, percentage of time spent in the bright
compartment (ANOVA: genotype F1,16 = 7.393, P = 0.0152). Reduced scores
at 9-month-old animals indicate increased anxiety.
D Exploratory corner visits in dark and light phase during adaptation to the
IntelliCage (ANOVA: phase F1,18 = 617.2, P < 0.0001). Corner visits during
the dark phase as a correlate of exploratory activity showed premature
reduction in 9-month-old animals.
E Learning in the hippocampus-dependent IntelliCage serial reversal task
(ANOVA: day F2,56 = 26.71, P < 0.0001). Scores provided no evidence for a
mutation effect on learning rate or performance.
F Learning in the hippocampus-dependent IntelliCage chaining task (ANOVA:
day F2,54 = 450.1, P < 0.0001). Scores provided no evidence for a mutation
effect on learning rate or performance.
G Water-maze place navigation, swim path during acquisition, and reversal
(ANOVA: day F4,104 = 21.14, P < 0.0001, genotype F1,26 = 13.11, P = 0.0013,
age × genotype F2,26 = 8.204, P = 0.0017). All groups learned: Controls
showed reduced performance with increasing age, and mutants showed
poor performance already at 9 and 14 months.
H Number of wall approaches as indicator of poor coping with the test and
non-spatial strategy choice (ANOVA: genotype F1,26 = 18.31, P = 0.0002, age
F2,26 = 4.486, P = 0.0212, age × genotype F2,26 = 7.068, P = 0.0035).
Number of wall approaches increased with age in controls and was
prematurely increased in mutants at 9 and 14 months.
I Water-maze probe trial, spatial retention score for target zones 1–3
comprising 5, 10, and 10% of the pool surface versus remaining 75% of
surface (ANOVA: zone F3,78 = 36.04, P < 0.0001, genotype × zone
F3,78 = 7.807, P = 0.0001). Spatial selectivity declined with age in controls
and was prematurely reduced in mutants at 9 and 14 months.
Data information: Graphs show mean and SEM. Post hoc FDR corrected,
***P < 0.001, **P < 0.01, *P < 0.05, ~P < 0.1, ns P ≥ 0.1. White boxes = t-test
for genotype within age cohorts, colored boxes = ANOVA age effects
contrasting between genotypes. 34 mice, n = 17 per genotype, n = 9–13 per
age cohort.
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se did not affect fundamental auditory function (Fig 6). Following
an exposure to noise (2–10 kHz broadband at intensities of 108 and
110 dB), ABR thresholds were determined 3 weeks later when
damage to the auditory system was stabilized. Exposure to noise
resulted in increases in ABR thresholds at 12, 24 and 32 kHz. The
noise-induced auditory damage was significantly more pronounced
in Mrps5V338Y/V338Y mice than in the control littermates as evidenced
by consistently larger threshold shifts at all three frequencies.
Furthermore, while control mice showed a graded response to noise
with increasing thresholds from 108 to 110 dB, V338Y mutants
demonstrated a ceiling effect already at 108 dB corroborating their
heightened susceptibility to noise trauma (Fig 6).
Discussion
By genetic manipulation of the nuclear-encoded mitochondrial ribo-
somal protein MRPS5, we have established the first-ever reported
mammalian model of a mitochondrial ram mutant. Following the in
silico identification of a putative ram mutation in mammalian
MRPS5 (human V336Y, mouse V338Y), phylogenetic reconstruc-
tions provided evidence that the corresponding mutation A127Y in
homologous bacterial ribosomal protein rpsE (E. coli) results in
mistranslation as evidenced by increased incorporation of near-
cognate aa-tRNA species and stop codon read-through. In the
absence of established means to introduce reporter genes into mito-
chondria of higher eukaryotes, we identified the mtDNA-encoded
MT-CO1 protein as an endogenous reporter of mitoribosomal
misreading. Using bacterial mitohybrid ribosomes with and without
the pathogenic A1555G mutation and translating MT-CO1 mRNA in
the absence and presence of the misreading agent tobramycin, we
established that both the ratio of cysteine/methionine incorporation
and the read-through in MT-CO1 protein translation constitute
markers of ribosomal misreading. Subsequently, we directly demon-
strated by mitochondrial in organello translation that the MRPS5
mutation V336Y increases both the ratio of cysteine/methionine
incorporation and read-through of endogenous MT-CO1, as does
treatment with tobramycin.
We found that mutant MRPS5-mediated mitochondrial mistrans-
lation in homozygous knock-in Mrps5V338Y/V338Y mice is associated
with impaired mitochondrial function in post-mitotic cells in vivo.
Brain cortical mitochondria showed a significant reduction in basal
respiration and maximal respiratory capacity, decreased ATP levels,
and increased formation of ROS. The cognitive performance of
mutant Mrps5 mice was apparently normal under non-aversive
conditions. However, we observed age- and stress-related alter-
ations in three behavioral traits in Mrps5 V338Y mutant mice: first,
increased anxiety responses as evidenced by less time spent in the
center of the open field and more time spent in the dark chamber of
the light–dark transition test; second, decreased explorative drive as
revealed by diminished vertical activity and a smaller area explored
in the open field; and third, impaired learning and memory under
stressful conditions as shown by poor training and probe trial scores
in the water-maze place navigation tests. The same combination of
behavioral differences characterized the transition from adulthood
to old age in the wild-type control mice, reflecting normal
behavioral aging. The triad of symptoms observed in Mrps5 mutant
mice—increased vigilance to threat, reduced exploratory drive, and
impaired coping with stress—is typical for physiological behavioral
aging in humans and rodents [30–33]. Thus, impaired mitochondrial
respiration in part phenocopied non-cognitive age-associated alter-
ations in brain function. The pathological phenotype of neurological
stress intolerance and anxiety-related behavioral alterations in
Mrps5V338Y/V338Y mice points to a key role for mitochondrial func-
tion in stress-associated behavioral adaptations [34–36].
Auditory studies revealed another compelling example of a mito-
chondria-related pathology in the mutants. Auditory thresholds,
reflecting the integrity of sensory hair cells and ascending auditory
pathways, are normal in V338Y mutant animals compared to litter-
mate controls. This mirrors the normal hearing phenotype of most
A1555G patients. The A1555G mutation shows a variable phenotype
from lifelong normal hearing to severe hearing loss, pointing to a
role for additional genetic and environmental stress factors neces-
sary for expression and exacerbation of a pathological phenotype
[37,38]. Notable stressors for the A1555G mutation are aminogly-
coside antibiotics whose administration can lead to sudden
profound hearing loss [13]. The hypersusceptibility to aminogly-
coside ototoxicity in A1555G patients is at least in part conferred by
increased binding of the drug to its target—rRNA residue 1555 is
part of the drug binding pocket in the ribosomal A-site [19]. In the
absence of increased binding of aminoglycosides to mutant V338Y
ribosomes—the ribosomal protein MRPS5 is not part of the drug
binding pocket—we decided to use noise trauma as a particular
pertinent stressor because of its traumatic mechanisms impinge on
sensory hair cell mitochondria [29]. Compared to wild-type control
mice, mutant V338Y mice showed significantly heightened suscepti-
bility to noise trauma. The increased loss of auditory function in
Mrps5V338Y/V338Y mutant mice observed upon exposure to noise
apparently results from noise-induced enhanced ROS formation,
ATP depletion, and mitochondrial cell death signaling [39,40],
superimposed on an already mutation-mediated compromised mito-
chondrial function.
In contrast to several human disease-causing mutations in mito-
chondrial tRNAs and nuclear genes encoding mitochondrial aminoa-
cyl-tRNA synthetases [11,22], the mutant MRPS5 mice display a
remarkable absence of overt pathology in vivo. While this surprising
Figure 6. Noise-induced hearing damage.
Noise exposure and ABRmeasurements. Exposure of mice to broadband noise (2–
10 kHz) of either 108 or 110 dB SPL resulted in elevations of auditory thresholds.
Thresholds inMrps5V338Y/V338Y mutant mice (black bars) were significantly higher
after exposure than thresholds in littermates (open bars); P < 0.0001 (two-way
ANOVA for combined 108 and 110 dB data). Frequencies of 12, 24, and 32 kHz
were selected for measurement to cover the mid-frequency to high-frequency
regions of the cochlea. n = 6 for baseline littermates; n = 6 for baseline mutants;
n = 3 for all noise exposures. Graphs show mean and SEM.
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observation may reflect a threshold effect of the mutation studied,
our findings are supported by the only discrete alterations observed
in humans with the mechanistically similar pathogenic A1555G
mutation [37]. Our results from whole genome transcriptome analy-
ses of the V336Y mutant HEK cells are in agreement with microar-
ray-based studies in immortalized lymphocytes of individuals with
the mitochondrial A1555G mutation which revealed little changes,
except for a coordinated upregulation of cytosolic ribosomal
proteins, an effect that was suggested as a compensatory mecha-
nism for the mitochondrial dysfunction associated with the A1555G
mutation [41]. In addition to a possible threshold effect, the most
probable explanation for the lack of overt pathology in A1555G
patients and MRPS5 V338Y mutant mice may reside in the nature of
ribosomal misreading. Disease-causing mutations in mitochondrial
tRNA or aminoacyl-tRNA synthetases affect a specific tRNA and
every molecule thereof with detrimental consequences for transla-
tion [22,42,43]. In contrast, misreading by ram mutations affects
translational accuracy in a random and stochastic manner, which
apparently can be in part tolerated. In addition, while ram muta-
tions, such as A1555G or MRPS5 V338Y, may allow for increased
rates of near-cognate misreading, the incorporation of non-cognate
amino acids during translation is prevented by the difference in the
free binding energy between cognate and non-cognate aa-tRNAs
[44].
In conclusion, by mutagenesis of nuclear-encoded mitochondrial
protein MRPS5 we have established a unique model of mitoriboso-
mal misreading that recapitulates the suggested A1555G pathomech-
anism [15–19]. Evidence is provided that increased mitochondrial
misreading is indeed the cause of hearing loss in the A1555G
patients. The model reproduces the hearing-related deficit as well as
the absence of overt non-cochlear pathology that distinguishes
A1555G from classical mitochondrial diseases [11,22]. Further, the
neurological alterations observed under adverse conditions and the
noise-induced auditory trauma found in MPRS5 mutant mice point




For generation of merodiploid M. smegmatis rpsE S152Y, genomic
DNA from M. smegmatis served as template for rpsE gene amplifi-
cation. Fusion PCR via complementary overhanging sequences was
used for gene construction. The first PCR used 50 primer fwd1 (50-
ATA CAA AAC CAG GTC AGG AGA TCG AAT GGC CGA GCA GGC
TGG CGC-30, native leader sequence of the rpsE operon at the 50
end) and 30 primer rev1 (50-ACT ACT AGT TTA TGC CGA TCC CTC
ACG CG-30, SpeI ACTAGT recognition site at the 30 end) to amplify
the rpsE coding DNA sequence (CDS). The second PCR used plas-
mid pMIH [45] as template and 50 primer fwd2 (50-ACT AAG CTT
CGG TGA CCA CAA CGC GCC CG-30) and 30 primer rev2 (50-TCG
ATC TCC TGA CCT GGT TTT GTA TCG CAA TTG TCT TGG CCA
TTG-30) to amplify the hsp60 promotor with a HindIII AAGCTT
recognition site at the 50 end. The two amplicons overlap at the
leader sequence and were fused using pfu polymerase (Promega),
subcloned into the pGEM-T Easy vector (Promega), and controlled
by DNA sequencing. PCR-mediated site-directed mutagenesis was
used to introduce the S152Y mutation. The constructs were cloned
into integrative vector pMIH using restriction enzymes HindIII and
SpeI (Thermo Fisher) resulting in vectors pMIH-rpsE-wt and pMIH-
rpsE-S152Y, respectively. Vectors pMIH-rpsE-wt and pMIH-rpsE-
S152Y were electroporated into M. smegmatis mc2155 DrrnB [46].
Single colonies were picked, propagated for further analysis, and
checked by PCR and DNA sequence analysis.
For the generation of E. coli rpsE A127Y, Oligo k Red-mediated
recombination was used as described previously [47]. In brief, two
steps of recombineering were conducted, using E. coli MG1655 and
oligonucleotides that comprised the A127Y mutation or the wild-
type sequence, respectively. Positive clones were screened by PCR
and confirmed by DNA sequencing. The recombinant E. coli strains
were a kind gift of Diarmaid Hughes and Douglas Huseby, Uppsala
University, Sweden.
For growth experiments, bacterial strains were streaked on agar
plates and grown at 37°C until single colonies were visible. Single
colonies were used to inoculate liquid LB medium. Growth experi-
ments were started at an initial OD600 of 0.002 and further incubated
at 37°C. OD600 was measured every 30 min for E. coli and every 3 h
for M. smegmatis. Signal intensities at time point 0 h were set as
one, and growth curves were plotted. Doubling time was calculated
as tD = ln(2)/slope.
Cell-free luciferase translation assays
Purified bacterial 70S ribosomes were used in dual luciferase trans-
lation assays as previously described [48,49]. A typical translation
reaction (30 ll) contained 0.25 lM 70S ribosomes, 4 lg firefly
(F-luc) and 0.4 lg Renilla (R-luc) mRNA, 40% (vol/vol) of M. smeg-
matis S100 extract, 200 lM amino acid mixture, 24 units of
RiboLock (Thermo Fisher), and 0.4 mg/ml of tRNAs—energy was
supplied by the addition of 12 ll of commercial S30 Premix without
amino acids (Promega). The reaction mixture was incubated at 37°C
for 35 min, stopped on ice, and assayed for F-luc and R-luc luci-
ferase activities according to supplier’s protocol (Promega). Lumi-
nescence was measured using the FLx800 luminometer (BioTek
Instruments).
Mistranslation was determined as described previously [50,51].
In brief, to assess misreading His245 (CAC codon) of the F-luc gene
was replaced by the near-cognate codon CGC or the non-cognate
codon AGA, both encoding for Arg. To determine read-through, the
Asp357 (GAC codon) of the F-luc gene was replaced by the
nonsense TGA stop codon. Arg245F-luc mRNA, X357TGA F-luc
mRNA, and WT F-luc mRNA were used in in vitro translation reac-
tions, and R-luc mRNA was used as internal control. Mistranslation
was calculated by the ratio of mutant firefly/Renilla luciferase activ-
ity to wild-type firefly/Renilla luciferase activity.
Cell culture and transfection of HEK293 cells
Human embryonic kidney cells (HEK293, Innoprot) were main-
tained in complete Dulbecco’s modified Eagle’s medium (DMEM)
(Life Technologies) containing 10% fetal bovine serum (FBS) (Life
Technologies), at 37°C in 5% CO2.
Plasmid pmouseMrps5-WT containing the mouse Mrps5 coding
region under the control of the chicken b-actin promotor and the
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CMV enhancer (CAGGS promotor) was constructed by Genoway
(Lyon, France). In brief, the mouse Mrps5 wild-type CDS was
synthesized, and restriction sites BamHI and AvrII were introduced
at the 50 and the 30 ends. Using the BamHI and AvrII restriction sites,
the 1,318-nt-sized fragment was ligated into an eukaryotic expres-
sion vector, which in addition to the CAGGS promotor carries the
human growth hormone polyadenylation signal, resulting in pmou-
seMrps5-WT.
The plasmid expressing the human MRPS5 gene was constructed
as follows. A cDNA fragment containing human MRPS5 wild-type
CDS was generated by PCR, using cDNA reverse-transcribed from
total RNA extracted from HEK293 cells. Total RNA was prepared
using TRIzol (Life Technologies) and DNase-treated (DNase I, Life
Technologies) by incubation for 15 min at 37°C; 1 ll of 25 mM
EDTA was added, and samples were incubated for 10 min at 65°C
and stored at 80°C. RNA was reverse-transcribed using a High
Capacity RNA-to-cDNA Kit (Life Technologies) according to the
manufacturer’s instructions. V336Y (GTC?TAC) point mutation
was introduced by PCR-mediated site-directed mutagenesis, and
restriction sites for BamHI and XhoI were introduced at the 50 and 30
ends, respectively. The mouse Mrps5 wild-type CDS in the pmou-
seMrps5-WT vector was replaced with human MRPS5 wild-type or
human MRPS5 V336Y using BamHI/XhoI restriction sites, resulting
in vectors pMRPS5WT and pMRPS5V336Y. IRES-eGFP was amplified
from plasmid pLZRSpBMN-IRES-eGFP (a kind courtesy of Saule
Zhanybekova, University of Basel, Switzerland) and inserted down-
stream of the MRPS5 CDS using restriction sites for BstBI and ClaI,
resulting in vectors pMRPS5WT-IRES-eGFP and pMRPS5V336Y-
IRES-eGFP. The hygromycin B resistance cassette was amplified by
PCR from vector pGL4.14 (Promega), subcloned into pGEM-T Easy
and inserted into pMRPS5WT-IRES-eGFP and pMRPS5V336Y-IRES-
eGFP using MluI-specific restriction sites.
For generation of stable transfectants, HEK293 cells were trans-
fected with vectors pMRPS5 V336Y-IRES-eGFP and pMRPS5WT-
IRES-eGFP using TurboFect (Thermo Fisher) according to the manu-
facturer’s instructions. Cells were cultured in DMEM supplemented
with 10% FBS and propagated under hygromycin B (100 lg/ml)
selection for 5–7 weeks. GFP-expressing colonies were picked for
further characterization. GFP fluorescence was analyzed by flow
cytometry using the BD FACSCanto II (BD Biosciences) and the
FlowJo data analysis software (Tree Star Inc.).
Determination of MRPS5 mRNA expression
Quantitative PCR was used to determine MRPS5 transgene mRNA
expression relative to endogenous MRPS5 mRNA levels. Total RNA
was prepared using TRIzol extraction and reverse-transcribed using
the High Capacity RNA-to-cDNA Kit (Life Technologies) according
to the manufacturer’s instructions. A 221-nt fragment from MRPS5
cDNA was amplified by using 50 primers binding specifically either
to the endogenous or the transgene MRPS5 50-UTR (50-TGC CCT
GGG CGG AGG CCG AGG CGC GGC TC-30—forward endogenous
gene-specific; 50-GAT CAG AAG CTT CGT TAA CTG AGC TCA GG-
30—forward transgene-specific) and a 30 primer binding to both
endogenous and transgene MRPS5 (50-GGC GTA GGG ATG GGT
GTC TCT GGT TCC CAG-30—reverse). For each sample, SYBR Green
qPCR was conducted in triplicate using EvaGreen qPCR Mix
(Bio&Sell) and ABI 7500 Fast Real-Time PCR System (Life
Technologies). Amplification consisted of 40 cycles (95°C for 20 s
and 60°C for 45 s), and specificity of amplification was confirmed
by melting curve analysis. Expression levels of MRPS5 were quanti-
fied as previously described [52].
The ratio of MRPS5 transgene mRNA to endogenous MRPS5
mRNA for cell lines expressing mutant V336Y MRPS5 was deter-
mined using MRPS5 forward 50-CTG CCA CAG GGC CAT CAT CAC
CAT CTG C-30 and MRPS5 reverse 50-CGG AAG AGG CCC TGG GTG
AGG CTG AGC-30 primers flanking the site of mutation. These
primers amplify a 108-nt PCR fragment of both endogenous and
transgene MRPS5 mRNA. Discrimination was achieved by using
TaqMan probes that recognize specifically human wild-type endoge-
nous MRPS5 (50-CAT GTA TGC CAA GGT C-30, conjugated to NED)
or human mutant transgene MRPS5 V336Y (50-TAT GCC AAG TAC
TCT G-30, conjugated to FAM). For each sample, TaqMan qPCR was
conducted in triplicate using the TaqMan Kit (Life Technologies)
and the ABI 7500 Fast Real-Time PCR System (Life Technologies).
Amplification consisted of 40 cycles (95°C for 20 s and 60°C for
45 s), and the ratio of transgene versus endogenous MRPS5 was
calculated as described previously [52].
Cellular localization of the transfected MRPS5 protein
For cellular localization of the MRPS5 protein, we introduced a 33-
nt fragment GAG CAA AAG CTC ATT TCT GAA GAG GAC TTG
AAT coding for myc tag peptide EQKLISEEDLN at the C-termini of
both MRPS5 WT and MRPS5 V338Y by PCR, resulting in vectors
pMRPS5WTmyc-IRES-eGFP and pMRPS5V336Ymyc-IRES-eGFP.
HEK293 cells were transiently transfected using TurboFect and
cultured in DMEM supplemented with 10% FBS for 72 h. Cellular
localization of MRPS5 protein was assessed by Western blot of mito-
chondrial and cytosolic fractions using anti-myc antibody (ab9106,
Abcam).
Determination of ratio of mitochondrial DNA (mtDNA)/nuclear
DNA (nDNA), mitochondrial mass, ATP content, oxygen
consumption, and generation time in HEK293 cells
The mtDNA:nDNA ratio was determined as previously described
[53]. In brief, total DNA was extracted from cultured cells with
QIAamp DNA Mini Kit (Qiagen). For mtDNA, a fragment of MT-TL1
gene (tRNA leucine) was amplified with forward primer (50-CAC
CCA AGA ACA GGG TTT GT-30) and reverse primer (50-TGG CCA
TGG GTA TGT TGT TA-30), and for nDNA, a fragment of B2M gene
(beta-2-microglobulin) was amplified with forward primer (50-TGC
TGT CTC CAT GTT TGA TGT ATC T-30) and reverse primer (50-TCT
CTG CTC CCC ACC TCT AAG T-30). Amplification was performed in
an ABI 7500 real-time PCR system (Life Technologies) and consisted
of 40 cycles (95°C for 20 s, 62°C for 30 s), and specificity of amplifi-
cation was confirmed by melting curve analysis. Each sample was
measured in triplicate.
Mitochondrial mass was measured using MitoTracker Deep Red
FM and FACSCanto II (BD Biosciences) equipped with helium–neon
laser according to the manufacturer’s recommendations. HEK293
cells were seeded in a MULTIWELLTM 12-well plate (BD Falcon) at a
density of 5 × 104 cells per well and cultured overnight in DMEM
supplemented with 10% FBS. Cell culture medium was replaced
with DMEM containing 200 nM MitoTracker Deep Red FM, and cells
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were incubated for 30 min at 37°C and 5% CO2. Cells were washed
twice with PBS and detached from surface with Accutase (Thermo
Fisher) and analyzed by FACS.
Total ATP content was quantified using the bioluminescence-
based assay ViaLight Plus Kit (Lonza). 104 cells were seeded in
triplicate in a black 96-well plate (BD Falcon) and incubated for
48 h in 100 ll DMEM supplemented with 10% FBS. 5 ll Alamar
Blue (Life Technologies) were added to each well and incubated for
3 h. Alamar Blue was measured as an internal standard, followed
by measurement of ATP content according to the manufacturer’s
protocol.
Mitochondrial respiration was measured using the Seahorse
Bioscience XF24 analyzer. XF24 cell culture microplates (Seahorse
Bioscience) were coated using 50 mg/ml poly-D-lysine, and cells
were seeded at a density of 105 cells/well in 100 ll DMEM supple-
mented with 10% FBS. Cells were incubated for 3 h at 37°C and 5%
CO2 for attachment, medium was aspirated, replaced by DMEM
without FBS, and cells were incubated overnight. Prior to the experi-
ment, the plate was incubated 30 min at 37°C in a CO2-free incuba-
tor. Cells were subsequently washed with Mitochondrial Assay
Solution (MAS; 70 mM sucrose, 220 mM mannitol, 10 mM KH2PO,
4.5 mM MgCl2, 2 mM HEPES, 1 mM EGTA, 0.2% (w/v) fatty acid-
free BSA, pH 7.2 at 37°C) according to the manufacturer’s protocol
(Seahorse Bioscience). Measurements were performed in MAS,
supplemented with 10 mM pyruvate, 10 mM succinate, 2 mM
malate, and 0.2 nM Plasma Membrane Permeabilizer (PMP) reagent
(Seahorse Bioscience). The experiment started in a coupled state in
the presence of succinate, pyruvate, and malate (state 2, basal respi-
ration). State 3 was initiated following the injection of 55 ll of
40 mM ADP (4 mM final). State 4o was induced by addition of
62 ll of 25 lg/ml oligomycin (3 lg/ml final). State 3 uncoupled
(3u) was assessed after injection of 68 ll 40 lM FCCP (4 lM final)
before shutting down mitochondrial respiration by injecting 76 ll of
40 lM and 20 lM (4 lM and 2 lM final) of antimycin A and rote-
none, respectively. Drugs were purchased from Seahorse Bioscience.
Data were extracted from the Seahorse XF-24 software, and bioener-
getic parameters were calculated according to the manufacturer’s
guidelines.
Cellular growth was monitored using Alamar Blue (Life Tech-
nologies). HEK293 cells were seeded on 24-well plates (BD Falcon)
at low density and incubated in DMEM with 10% FBS at 37°C. 10%
Alamar Blue was added to the cells (v/v) at time points 0, 24, 48
and 72 h, and fluorescence was measured (excitation: 530 nm,
emission: 590 nm) after 3 h of incubation. Signal intensities at time
point 0 h were set as one, and growth curves were plotted. Doubling
time was calculated as tD = ln(2)/slope.
Cell-free MT-CO1 translation assays
Purified 70S M. smegmatis hybrid ribosomes were used in cell-free
translation assays. The mitochondrial COX1 gene (MT-CO1) was
redesigned for efficient bacterial translation: (i) The codon usage
was optimized for bacterial translation, (ii) an additional alanine
GCG codon was introduced after the ATG start codon to create
Kozak context, and (iii) the TAA stop codon was introduced instead
of AGA (hungry codon). To measure read-through, constructs MT-
CO1-AGA-polyA and MT-CO1-TGA-polyA were designed. MT-CO1-
AGA-polyA has the 69-nt-long native 30 UTR of human MT-CO1
mRNA followed by a 51-nt-long polyA sequence, MT-CO1-TGA-
polyA has a TGA stop codon instead of AGA. The constructs were
ordered from GenScript USA Inc. and cloned into the pUC57 vector
(Thermo Fisher). A typical translation reaction with the total
volume of 30 ll contained 0.25 lM 70S ribosomes, 4 lg of in vitro-
transcribed mRNA, 40% (vol/vol) of M. smegmatis S100 extract,
200 lM amino acid mixture without methionine, cysteine or lysine,
24 units of RiboLock (Thermo Fisher), and 0.4 mg/ml of tRNAs.
Energy was supplied by the addition of 12 ll of commercial S30
Premix without amino acids (Promega). Depending on the labeled
amino acid, 35S-methionine (KSM-01; Hartmann Analytic), 35S-
cysteine (ARS 0101; Hartmann Analytic), or 14C-lysine (ARS-0673;
Hartmann Analytic) were added; cold methionine, cysteine, or
lysine was subsequently added to a final concentration of 0.2 mM.
The reaction mixture was incubated at 37°C for 1 h and stopped on
ice. To reduce background and for quantification of radioactively
labeled bands, the products of the in vitro translation reaction were
immunoprecipitated. The purified proteins were analyzed on 15%
SDS–PAGE. As a control for MT-CO1, we used in organello transla-
tion products labeled with 35S-Methionine. The gel was fixed, dried,
and exposed on phosphor-imager screen and scanned with a FLA-
5100 laser scanner (Fujifilm). Intensity of MT-CO1 bands was quan-
tified using AIDA (version 3.52.046, raytest Isotopenmessgera¨te
GmbH).
Mitochondrial in organello translation
Mitochondria were isolated from HEK293 cells as described [54]. In
brief, HEK293 cells were collected from two 90% confluent petri
dishes, washed 3 times with PBS, and resuspended in 1 ml of
extraction buffer (20 mM HEPES-KOH (pH 7.5), 0.25 M sucrose,
10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM
DTT). Cells were broken by passing ten times through a syringe
needle (0.45 × 12 mm), centrifuged 5 min at 800 g, and supernatant
was transferred to a new tube. The pellet was resuspended in 1 ml
of extraction buffer, passed five times through a syringe needle
(0.45 × 12 mm), and centrifuged for 5 min at 800 g. The super-
natant was collected, combined with the previous supernatant, and
centrifuged 5 min at 800 g. The supernatant was collected and
centrifuged for 15 min at 10,000 g, and the resulting pellet was used
as the mitochondria-enriched fraction.
Mitochondrial in organello translation was done as described,
with slight modifications [55–57]. In brief, the mitochondria-
enriched pellet was resuspended in 1 ml of mitochondria reaction
buffer (MR-buffer) containing 20 mM Tris–HCl (pH 7.2), 90 mM
KCl, 4 mM MgSO4, 1.5 mM KH2PO4, 20 mM glutamate, 0.5 mM
malate, 14 mM sucrose, 44 mM sorbitol, 4 mM ADP, 0.1 mM amino
acids (without methionine and cysteine), 1 mg/ml BSA (fatty acids
free), and 0.1 mg/ml cycloheximide. Depending on the labeled
amino acid, 15 ll of 35S-methionine or 35S-cysteine was added. Cold
methionine or cysteine was subsequently added to a final concentra-
tion of 0.1 mM. The resulting master mix was split into 100 ll per
translation reaction. In organello translation was conducted by incu-
bation at 30°C for 2 h on a shaker (800 rpm). After incubation, the
reaction mixtures were centrifuged for 5 min at 15,000 g, and the
supernatants were discarded. The pellets were washed with cold
washing buffer containing 10 mM Tris–HCl (pH 7.4), 320 mM
sucrose, 1 mM EDTA, centrifuged for 5 min at 15,000 g, and
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resuspended in 20 ll of 1× SDS loading buffer or in 30 ll H2O for
subsequent immunoprecipitation. The samples were analyzed on
15% SDS–PAGE. The gel was fixed, dried, and exposed on phos-
phor-imager screen and scanned with laser scanner FLA-5100.
Intensity of bands was quantified using AIDA.
Immunoprecipitation
In brief, for one reaction 50 ll of Dynabeads M-280 sheep anti-
mouse IgG (11202D, Thermo Fisher) or sheep anti-rabbit IgG
(11204D, Thermo Fisher) was washed 3 times with 1 ml of blocking
solution (PBS with 0.5% BSA). For immobilization of antibodies,
Dynabeads were incubated with 5 lg of monoclonal MT-CO1 anti-
body (ab14705, Abcam), monoclonal MT-CO2 antibody (ab110258,
Abcam), or polyclonal antibody against Lys14 (customized antibody,
GenScript USA Inc.) in 1 ml of blocking solution overnight at 4°C,
subsequently washed three times with blocking solution, and resus-
pended in 50 ll of blocking solution.
To 30 ll of bacterial or in organello translation reaction, 20 ll of
20× IP buffer (0.4 M Tris–HCl, pH 7.5, 1.5 M NaCl, 0.5% SDS, 10%
Triton X-100, 10 mM EDTA) was added, incubated for 30 min at
room temperature, and H2O was added to a final volume of 350 ll.
50 ll of Dynabeads with the immobilized antibodies was added to
the translation mixture and incubated overnight at 4°C while shak-
ing. The Dynabeads were washed with blocking solution, pelleted,
and resuspended in 20 ll of H2O. 6 ll of 4× SDS loading buffer was
added and vortexed. The samples were heated at 95°C for 5 min
and resolved on 15% SDS–PAGE. The gel was fixed, dried, and
exposed on phosphor-imager screen and scanned with laser scanner
FLA-5100. Intensity of MT-CO1 and MT-CO2 bands was quantified
using AIDA. For validation of antibodies used, see Fig 2F and G.
MT-CO1 translation in rabbit reticulocyte lysate
MT-CO1-AGA-polyA mRNA and MT-CO1-TGA-polyA mRNA were
used for translation in rabbit reticulocyte lysates. A typical transla-
tion reaction with a total volume of 30 ll contained 20 ll of rabbit
reticulocyte lysate (Promega), 4 lg of in vitro-transcribed mRNA,
200 lM amino acid mixture without methionine, 24 units of Ribo-
Lock (Thermo Fisher) and 1 ll of 35S-methionine (KSM-01; Hart-
mann Analytic). The reaction mixture was incubated at 37°C for 1 h
and stopped on ice. The products of the in vitro translation reaction
were immunoprecipitated using MT-CO1 or poly-lysine antibodies.
The immunoprecipitated proteins were analyzed on 15% SDS–
PAGE. As a control for MT-CO1, we used in organello translation
products labeled with 35S-methionine. The gel was fixed, dried, and
exposed on a phosphor-imager screen and scanned with a FLA-5100
laser scanner (Fujifilm).
Mitochondrial translation
HEK293 cells were grown in 10-cm petri dishes (BD Falcon) in
DMEM with 10% FBS to 80% confluence, washed, and incubated
for 30 min in DMEM without methionine. Media were exchanged to
DMEM without methionine supplemented with 100 lM emetine
(Sigma-Aldrich) and incubated for 15 min. The medium was
replaced with 500 ll methionine-free DMEM supplemented with
2 ll of 35S-methionine and 100 lM emetine, and cells were
incubated for 2 h at 37°C. The supernatant was carefully aspirated,
and cells were detached by pipetting with 1 ml of PBS. The cells
were washed 2 times with PBS and resuspended in 200 ll of 1× SDS
loading buffer. The samples were analyzed on a 15% SDS–PAGE.
The gel was fixed, dried, and exposed on a phosphor-imager screen
and scanned with the FLA-5100 laser scanner. A pilot experiment
was performed to control that emetine effectively inhibited cytosolic
protein synthesis and that the residual protein synthesis reflects
mitochondrial translation as shown by susceptibility to linezolid
(Pfizer) (Appendix Fig S3G).
Western Blot
Cells were grown to 70% confluence in DMEM with 10% FBS. Cells
were lysed with 1× Passive Lysis Buffer (Promega) and ultrasoni-
cated. Lysates were centrifuged (15,000 g, 10 min), and protein
concentration in the supernatant was measured by the Micro BCA
Protein Assay Kit (Thermo Fisher). Ten micrograms of total protein
was resolved on 10% SDS–PAGE and blotted on nitrocellulose
membranes, which were probed with specific antibodies. Amersham
ECL Prime Western blotting detection reagent (RPN2232; GE Health-
care) was used as substrate for horseradish peroxidase (HRP). The
specific antibodies used in this study were as follows: anti-myc tag
(ab9106, Abcam); anti HSP60 (ab46798, Abcam), anti-ATP6
(MS508, MitoScience), and anti-b-tubulin (ab15568, Abcam); HRP-
conjugated goat anti-rabbit (G-21234, Thermo Fisher); and goat
anti-mouse antibodies (A10551, Thermo Fisher).
Generation of Knock-In Mrps5 transgenic mice
Mrps5 V338Y mice were generated using a FLEx approach [58]. This
strategy is based on the duplication of the exon to be mutated and
its insertion in the antisense orientation. The duplicated regions are
flanked with loxP and lox511 cloned in opposite directions
(Mrps5FLEx allele). Upon Cre induction, the mutated exon will be
flipped resulting in the deletion of the wild-type exon and expres-
sion of the mutant protein (Mrps5V338Y allele).
The gene-targeting vectors were constructed from genomic 129Sv
mouse-strain DNA. For Mrps5 V338Y, exon 10 was duplicated and
the mutant exon inserted in antisense within intron 10. The inser-
tion points were selected in order not to disrupt any potential regu-
latory region identified by consensus sequences. The duplicated
exons were flanked by loxP and mutated lox511 sites for deletion of
the WT exon and switch of the mutant exon upon Cre-mediated
action. A Flippase Recognition Target (FRT)-flanked neomycin
cassette was cloned into the targeting vector. Linearized targeting
vectors were transfected into 129Sv ES cells, and positive selection
was started 48 h after electroporation by addition of G418. Resistant
clones were isolated, amplified, duplicated, and genotyped by both
PCR and Southern blot analysis. The following primer pairs were
designed to specifically amplify the targeted locus—34690sa: 50-
GGG AAC TTC CTG ACT AGG GGA GGA GTA G-30, 34691sa: 50-
GCA AAG ACT CAG ACA AAC AAC CGA CG-30. Targeted locus was
confirmed by Southern blot analysis using internal and external
probes on both 50 and 30 ends. PCR and Southern blot genotyping
led to the identification of two targeted clones for Mrps5 V338Y.
Recombined ES cell clones were microinjected into C57BL/6
blastocysts and gave rise to male chimeras. Breeding with C57BL/6
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Flp deleter mice (CAG-Flp) was performed to produce the Mrps5
heterozygous inducible line devoid of neomycin cassette: Mrps5FLEx/
WT. Inducible mice were backcrossed to C57BL/6 for four genera-
tions. The inducible Mrps5 V338Y line was crossed to C57BL/6 CRE
deleter mice (CMV-Cre) to produce the Mrps5 V338Y heterozygous
induced mutant line. Cre-recombination resulted in flipping of the
duplicated inverted exon bearing the mutation of interest (FLEx
strategy) and expression of the mutant allele, resulting in heterozy-
gous mutant line Mrps5V338Y/WT referred to as induced mice. For
each line, heterozygous mice were genotyped by PCR, Southern
blot, and sequencing (Appendix Fig S4).
Heterozygous inducible mice (Mrps5FLEx/WT) were first identified
by PCR using primer 017 (50-GCC AAA GAG ACA TGC AGT GAG
AAG AGT ACC-30) and primer 018 (50-CCA CCA TGA GTC CAA TGA
TTG CAC C-30). The primers result in amplification of a specific
1.0 kb fragment for the Mrps5FLEx allele, while wild-type Mrps5 does
not result in an amplicon. PCR-positive mice (Mrps5FLEx/WT) were
confirmed by Southern blot analysis using a 30 external probe (ampli-
fied using the following primers: 50-ACT TTA CAG CCT AGC TCG
TCA GCA CAG C-30, 50-CCC AAG CTA AGA CCC CTT TCA ACA
GC-30). Upon digestion with NheI, a 5.1 kb fragment is expected for
the Mrps5WT allele, and a 5.5 kb fragment is expected for the
Mrps5FLEx allele. Heterozygous induced mice (Mrps5V338Y/WT) were
genotyped by PCR using primers 34712hom (50-GCT TCT GTT TGT
GGC TTG TGT TGC C-30) and 34713hom (50-TTG TTG GAC TGG
TGA AAC ACC T CGG-30). The primers result in a 0.6 kb gene frag-
ment for the Mrps5WT allele, and a 0.8 kb gene fragment for the
Mrps5V338Y allele. Heterozygous induced mice (Mrps5V338Y/WT) were
confirmed by Southern blot analysis using a 50 external probe (ampli-
fied using the following primers: 50-GGT GGC TTT TGC AGT AAT
TTT ATT TACT TGC-30, 50-AAA CTC CCT AAG CTT CTC CCC ACA
CTC-30). Following digestion with AvrII/HpaI, the following frag-
ment sizes are expected for each allele: 9.6 kb for Mrps5WT, 7.9 kb
for Mrps5FLEx, and 7.2 kb for Mrps5V338Y. The presence of the muta-
tion in the induced mice (Mrps5V338Y/WT) was controlled by sequenc-
ing of a 2.8 kb product specific for the induced allele using primers
hybridizing to the loxP site (remaining upstream of exon 10 upon
induction) and downstream of exon 11. The primers used (primer
017: 50-GCC AAA GAG ACA TGC AGT GAG AAG AGT ACC-30,
primer 34709cof: 50-ATG AGG GGA GGG GCA GGA ACC TAA-30) will
not amplify the wild-type allele.
Mice tissue sections were frozen until RNA extraction was
performed. RNA was extracted using TRIzol as described above.
cDNA synthesis was performed using SuperScript II cDNA Synthesis
Kit (Life Technologies) using random hexamers and 40 ng RNA in
20 ll reagent according to the manufacturer’s protocol. Expression
of the mutant gene was assessed from brain, inner ear, and retina
recovered from 6- to 7-week-old animals. Heterozygous Mrsp5-
induced mice (Mrps5V338Y/WT) were compared to wild-type mice for
expression of the Mrps5 gene. RT–qPCR analysis showed no signifi-
cant difference in Mrps5 total mRNA between heterozygous induced
mutant mice and controls. Expression of the V338Y mutant allele
was demonstrated by sequencing of the RT–PCR product. Primers
used for RT–PCR and sequencing were EBO4-SeqF1 (50-GCT ATT
GGG AAA GCT GCT GA-30) and EBO4-SeqR2 (50-TCA CGT CCT GCC
AGT CCA GC-30). Primers used for RT–qPCR analysis were EBO4-
TOT-F1 (50-CCA TGA ACA TGC TCA ACC TC-30) and EBO4-TOT-R2
(50-ATA GGC AGA GGC CCA CAT T-30).
Heterozygous Mrps5V338Y/WT mice are viable, are fertile, and do
not show any gross phenotype. Heterozygous mutant mice bred
within the expected Mendelian ratio, suggesting that the mutation
has no significant effect on the viability of the line. Interbreeding
Mrps5V338Y/WT resulted in homozygous Mrps5V338Y/V338Y mice.
Analysis of Mrps5 gene expression in the homozygous mutant mice
revealed Mrps5 mutant mRNA only in all tissues tested
(Appendix Fig S4). The overall expression level of mutant Mrps5
mRNA was comparable to wild-type mice, indicating that the muta-
tion did not lead to deregulation of Mrps5 gene expression. Homozy-
gous mutant mice were able to breed and did not show any gross
phenotype.
RNA sequencing and data analysis
RNA sequencing (RNA-seq) was performed at the UZH/ETH Func-
tional Genomics Center Zurich (FGCZ) according to the Illumina
RNA sequencing protocol. For transcriptome analysis, four clones
of Mrps5 V336Y and six clones of Mrps5 wild-type transfected
cells were compared. RNA was extracted using TRIzol. The qual-
ity of the isolated RNA was determined using a Qubit (1.0) Fluo-
rometer (Life Technologies) and a Bioanalyzer 2100 (Agilent).
Only those samples with a 260 nm/280 nm ratio between 1.8 and
2.1 and a 28S/18S ratio within 1.5-2 were further processed. The
TruSeq Stranded mRNA Sample Prep Kit (Illumina) was used in
the succeeding steps. Briefly, total RNA samples (100–1,000 ng)
were ribosome-depleted and then reverse-transcribed into double-
stranded cDNA with actinomycin added during first-strand synthe-
sis. The cDNA samples were fragmented, end-repaired, and
polyadenylated. TruSeq adapters containing the index for multi-
plexing were ligated to the fragmented DNA samples. Fragments
containing TruSeq adapters on both ends were selectively
enriched with PCR. The quality and quantity of the enriched
libraries were validated using the Qubit (1.0) Fluorometer and
LabChip GX (Caliper Life Sciences). The product is a smear with
an average fragment size of approximately 360 bp. The libraries
were normalized to 10 nM in Tris-Cl 10 mM, pH 8.5 with 0.1%
Tween-20. The TruSeq SR Cluster Kit v4-cBot-HS (Illumina) was
used for cluster generation using 8 pM of pooled normalized
libraries on the cBOT. Sequencing was performed on the Illumina
HiSeq 2500 single end 126 bp using the TruSeq SBS Kit v4-HS
(Illumina). The quality of the reads was assessed using FastQC
(Babraham Bioinformatics), and potential contaminations were
evaluated with FastQ Screen (Babraham Bioinformatics) using
bowtie2 v. 2.1.0 default parameters [59]. Quantification of gene
expression was performed using the RSEM package (version
1.2.18) [60] mapping against the ensembl 75 annotations derived
from the human genome assembly GRCh37 and mouse genome
assembly GRCm37. Genes not present (< 10 counts per gene) in
at least 50% of samples from one condition were discarded from
further analyses. Differential gene expression analysis between
sample groups of interest was performed using the R/bioconduc-
tor package edgeR [61]. To evaluate functional activities, differen-
tially expressed genes were mapped to known biological
ontologies based on the GO project using gene annotation tool
Enrichr [62,63].
Transcriptome data are available in Gene Expression Omnibus
(GEO), accession no. GSE101503.
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Histopathological analyses
Mutant Mrps5V338Y/V338Y mice of 9 months of age were histologi-
cally analyzed in comparison with age-matched wild-type litter-
mates (three animals per group). 4-lm sections of formalin-fixed,
paraffin-embedded (FFPE) brain and cerebellum were subjected to
hematoxylin–eosin (H&E) staining. In addition, FFPE brain sections
were Holmes–Luxol-stained (to assess axon integrity and myelina-
tion status) and processed for immunohistochemistry (IHC) using
anti-GFAP from DAKO (1:500) and anti-Iba1 from Wako (1:3,000);
secondary antibody was anti-rabbit IgG (Vector; ImmPRESS Reagent
Kit).
Cortical brain homogenate preparation
Isolated cortical hemispheres were dissected on ice, washed in ice-
cold buffer 1 (138 mM NaCl, 5.4 mM KCl, 0.17 mM Na2HPO4,
0.22 mM K2HPO4, 5.5 mM glucose, 58.4 mM sucrose, pH 7.35), and
homogenized with a glass homogenizer (10–15 strokes, 400 rpm) in
2 ml of ice-cold buffer 2 (210 mM mannitol, 70 mM sucrose,
10 mM HEPES, 1 mM EDTA, 0.45% BSA, 0.5 mM DTT, 5×
Complete Protease Inhibitor (Roche Diagnostics).
Preparation of isolated mitochondria
Cortical brain homogenates were centrifuged at 1,450 g for 7 min
at 4°C to remove nuclei and tissue particles; centrifugation was
repeated with the supernatant fraction for 3 min [64]. The result-
ing supernatant fraction was centrifuged at 10,000 g for 5 min at
4°C to pellet mitochondria. The resulting pellet was resuspended
in 1 ml of ice-cold buffer 2 and centrifuged at 1,450 g for 3 min at
4°C to remove debris. The mitochondria-enriched supernatant was
centrifuged at 10,000 g for 5 min at 4°C to obtain the mitochon-
drial fraction. This fraction was resuspended in 300 ll of PBS and
stored at 4°C until use, followed by determination of protein
content.
Oxygen consumption and ATP measurements in isolated
brain mitochondria
Rates of oxygen consumption were measured in isolated cortical
mitochondria using a Seahorse Bioscience XF24 Analyzer, following
the manufacturer’s protocol and as previously described [64].
Briefly, mitochondria were diluted 1:10 in cold 1× MAS containing
10 mM succinate, 2 mM malate, and 10 mM pyruvate. 50 ll of
mitochondrial suspension (5 lg mitochondrial protein/well) was
delivered to each well of a XF Cell Culture microplate (except for
background correction wells) and centrifuged at 2,000 g for 20 min
at 4°C to let mitochondria adhere to the wells. After centrifugation,
450 ll of pre-warmed (37°C) 1× MAS plus substrates was added to
each well and the plate was incubated 5 min at 37°C in a CO2-free
incubator prior to the experiment. The plate was placed in a XF24
Analyzer, and oxygen consumption rates were assessed under dif-
ferent respiratory states as described above for HEK293 cells, except
that oligomycin was added to a final concentration of 2.5 lg/ml.
ATP content was determined using ViaLight Plus Kit (Lonza)
following the manufacturer’s instructions and normalization per
protein content.
Complex IV and complex II measurements in isolated
brain mitochondria
Mitochondrial complex IV activity was determined in intact isolated
mitochondria (1 lg) using the Cytochrome c Oxidase Assay Kit
(Sigma) as previously described [65]. The colorimetric assay is
based on the observation that a decrease in absorbance at 550 nm
of ferrocytochrome c is caused by its oxidation to ferricytochrome c
by cytochrome c oxidase. Briefly, the assay was performed in a 96-
well plate. Isolated mitochondria were diluted in enzyme dilution
buffer (10 mM Tris–HCl, 250 mM sucrose, pH 7) to a final concen-
tration of 0.2 lg/ll. 5 ll of the mitochondrial solution was added
per well. Subsequently, 195 ll of assay buffer (10 mM Tris–HCl,
120 mM KCl, pH 7) was added, then 10 ll of ferrocytochrome c was
injected in each well, and the absorbance at 550 nm was measured
for 60 s using a Victor X5 multi-wavelength reader (PerkinElmer).
Mitochondrial complex II activity was determined in intact
isolated mitochondria using complex II-mediated reduction of 2,6-
dichlorophenolindophenol (DCIP). Isolated mitochondria were
placed in 1 ml of medium containing 60 mM KH2PO4 (pH 7.4),
3 mM KCN, 20 lg/ml rotenone, 20 mM succinate, and 5 lg mito-
chondrial protein. The reaction was initiated by the addition of
1.3 mM phenazine methosulfate (PMS) and 0.18 mM DCIP. Reduc-
tion of DCIP was followed by measuring the decreasing absorbance
at 600 nm. The extinction coefficient used for DCIP was 21 mM/cm.
Complex IV and II activities were normalized as per mg protein
content.
Determination of superoxide anion radicals
MitoSOXTM Red reagent (Thermo Fisher) is a fluorogenic dye specifi-
cally targeted to mitochondria in live cells. Oxidation of MitoSOXTM
Red reagent by superoxide produces red fluorescence. Cortical brain
homogenate samples were adjusted to 1 mg protein/ml in HBSS.
150 ll of a 5 lM MitoSOXTM reagent working solution (prepared
according to the manufacturer’s protocol) was added to 250 ll
sample, followed by incubation at 37°C for 10 min, protected from
light. Then, samples were centrifuged for 3 min at 500 g. After
discarding the supernatant, the pellets were washed three times with
250 ll HBSS (3 min at 500 g). Finally, the samples were transferred
into a 96-well plate (final volume 100 ll per well) and fluorescence
was detected using the Victor X5 multiplate reader at 510 nm (excita-
tion) and 580 nm (emission). The intensity of fluorescence is propor-
tional to superoxide anion radicals in mitochondria.
Noise exposure and auditory brain stem response
Male C57BL/6 mice were first exposed for 2 h to broadband noise
(2–10 kHz) at intensities of 104, 106, 108, and 110 dB. ABR thresh-
olds were determined 3 weeks later when damage to the auditory
system has stabilized and is no longer confounded by transient
impairment of sound processing. The frequencies of 12, 24, and
32 kHz were selected for measurement to cover the mid-frequency
to high-frequency regions of the cochlea. Exposures at noise intensi-
ties of 108 and 110 dB resulted in robust elevations of ABR thresh-
olds and were chosen as treatment for mutant Mrps5V338Y/V338Y
mice and littermate controls. Sham-exposed controls (2 h in the
exposure chamber without sound) showed no effect on ABR.
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Animals for behavioral analysis
Mice were housed under a 12/12-h light–dark cycle (lights on at
20:00) in groups of 2–5, unless individual housing was required by
experimental protocols. Mice were tested during the dark phase of
the cycle under indirect dim light (ca. 12 lux) unless specified other-
wise. Before behavioral testing, each mouse was tagged by subcuta-
neous injection of a RFID microchip (Planet ID GmbH) under brief
isoflurane inhalation anesthesia. Three cohorts comprising a total of
34 female mice were examined in the same sequence of behavioral
tests (in the order listed below) starting at the age of approximately 9
and 19 months, and selected tests were also recorded at 14 months.
IntelliCage system
The IntelliCage apparatus (TSE Systems) was placed in a polycar-
bonate cage (20.5 cm high, 58 × 40 cm top, 55 × 37.5 cm bottom,
Techniplast, 2000P) and accommodated up to 16 mice [66]. A food
rack provided standard mouse chow ad libitum. Woodchip bedding
as well as four standard red shelters were provided. Four triangular
conditioning chambers (15 × 15 × 21 cm) were fitted in the cage
corners. Two drinking bottles were accessible in each of them
behind motorized doors. Visits, nosepokes, and licks were recorded
and assigned to individual mice through a RFID antenna at the
chamber entrance. A PC running IntelliCage Plus software (TSE
Systems) collected the data and controlled the experiments. Testing
began by free adaptation (7 days) providing access to all bottles
with doors open at all times. During subsequent nosepoke adapta-
tion (3–7 days), doors were closed but could be opened at any time
by a nosepoke. Finally, drinking session adaptation (4–7 days)
shaped mice to drink only during 4 1-h drinking sessions each day.
The following learning tasks were based on the same drinking
session schedule [67]. In all of them, percentage of rewarded visits
with nosepokes served as measure of performance. In the corner-
preference task, each mouse could obtain water only in one of the
four corners during 4 days. In the corner-preference serial reversal
task (7 days), the mice had to learn a new corner during every
drinking session. During the final chaining task (10 days), the mice
had to visit corners in a clock or anti-clockwise sequence to get
water.
Individual home cage activity
Diurnal home cage activity of individually housed mice was
recorded during 7 days under the standard light cycle using a rack
of type II long mouse cages (365 mm long × 207 mm
wide × 140 mm high) equipped with one passive IR sensor per
mouse (ActiviScope, New Behavior Inc) [68].
Video tracking
During open field and water-maze tests, on the elevated O-maze,
and during the light–dark transition test, the mice were video-
tracked using a Noldus EthoVision 3.00 system (Noldus Information
Technology). The system recorded position, object area, and the
status of defined event recorder keys on the keyboard. Raw data
were then transferred to public domain software Wintrack 2.4
(www.dpwolfer.ch/wintrack) for further analysis.
Open field
The round arena had a diameter of 150 and 35 cm high sidewalls
made of white polypropylene [68]. Each subject was released near
the wall and observed for 10 min on two subsequent days. Vertical
activity was estimated by counting reductions in object size in the
absence of locomotion.
Elevated O-maze
A 5.5-cm-wide annular runway with an outer diameter of 46 cm
was positioned 40 cm above the floor [68]. Two opposing 90°
closed sectors were protected by inner and outer walls (height
16 cm). The remaining two open sectors had no walls. Animals
were released near a closed sector and observed for 10 min. Head
dips were recorded using the keyboard event recorder. Head dips
that occurred while the animal kept its body between the protection
walls were classified as protected head dips.
Grip test
The grip meter consisted of a mechanical newton meter (max. force:
300 g) that was positioned horizontally 9 cm above a wooden plate
and attached to a metallic T-bar of 5 cm width and 3 mm thickness.
Mice were held by the tail and allowed to grasp the bar with both
forepaws. They were then gently pulled away until they released the
bar. Five consecutive measurements were obtained each during two
sessions with an interval of approximately 1 h [69].
Light–dark transition test
The apparatus consisted of a transparent chamber (20 × 30 cm, 20 cm
high) exposed to direct room light (ca. 450 lux) and connected to an
enclosed dark box (20 × 15 cm, 20 cm high) via a small opening [68].
Mice were released in the bright compartment and observed for 5 min.
Water-maze place navigation
The round white polypropylene pool had a diameter of 150 cm with
68 cm high walls. It was filled with water (24–26°C, depth 15 cm),
which was rendered opaque by addition of 1 l of milk (UHT whole
milk 3.5% fat, Coop). The white quadratic goal platform
(14 × 14 cm) was made of metallic wire mesh and painted white. It
was hidden 0.5 cm below the water surface in the center of one of the
four quadrants, approximately 30 cm from the side wall. Salient
extra-maze cues were placed on the walls of the testing room.
Animals performed 30 training trials (max. duration 120 s), 6 per day
with intertrial intervals of 30–60 min and varying starting positions.
During the first 18 trials, the hidden platform was held in the same
position (acquisition phase) and then moved to the opposite quadrant
for the remaining 12 trials (reversal phase). The first 60 s of the first
reversal trial served as probe trial to test for spatial retention.
Nesting test
Mice were provided with 3 g of compressed cotton (Plexx) in a
single cage and given 24 h to build a nest. Nests were assessed on a
rating scale of 1–5 [70].
ª 2018 The Authors EMBO reports e46193 | 2018 15 of 18
Rashid Akbergenov et al Mitoribosomal misreading EMBO reports
Published online: September 20, 2018 
Burrowing test
A gray plastic tube (inner diameter 6.3 cm, length 18.2 cm) with one
open end was filled with 350 g of standard diet food pellets and
placed at a slight angle into a large standard transparent type III cage.
Each mouse was given 24 h to remove pellets from the tube [71].
T-maze spontaneous alternation
Arms of the T-shaped maze measured 30 × 10 cm with 20 cm high
side walls. Goal and start arms could be blocked with manually
operated doors. Three trials each was run on two subsequent days
with an interval of about 60 min [72]. During the sample phase, the
animal was allowed to choose a goal arm and was confined to the
chosen goal arm for 30 s. After this, the animal was transferred back
to the start arm and again allowed to choose one of the goal arms
(choice phase).
Acoustic startle response
The SR-LABTM SDI startle response system (San Diego Instruments)
was controlled by proprietary SR-LAB software. The cylindrical
animal enclosure (28 × 89 mm) was made of clear Perspex, rested
on a plate with a motion sensor and was enclosed in a sound-atte-
nuated ventilated cabinet. The loudspeaker was located above the
animal and produced white noise pulses. To record a startle
response profile, 66 trials were presented in total after a habituation
time of 300 s. Nine different sound levels (dB) used were as follows:
64, 68, 72, 76, 80, 90, 100, 110, and 120. Each stimulus was 40 ms
and presented 6 times in pseudorandom order such that each sound
level occurred once within a block of nine trials. The series began
and ended with six presentations each of the 120 dB stimulus. The
average intertrial interval was 15 s (ranging from 10 to 20 s). The
startle response was recorded for 250 ms (measuring the response
every 1 ms) starting with the onset of the startle stimulus. Back-
ground noise was set at 64 dB during the entire session.
Hotplate test
To assess acute thermal nociception, the incremental hot/cold plate
analgesia meter (model PE34, IITC Life Science) was set to 55°C.
The animal was observed until it licked a hindpaw, jumped, or until
the cutoff time (60 s) was reached.
Water-maze cue navigation
Testing apparatus and procedures were the same as used for the
place navigation task, except that the platform was marked with a
salient local cue and moved to a new position for every trial. Each
mouse was trained for 2 days with six trials each.
Statistical analysis
Data from biochemical assays were analyzed with Prism 5.0 soft-
ware using unpaired Student’s t-test to determine the significance of
difference unless otherwise specified.
Data from behavioral studies were analyzed using an ANOVA
model with genotype (Mrps5V338Y/V338Y, Mrps5WT/WT) and age
cohort (9 months, 19 months) as between-subject factors. Within-
subject factors were added as needed to explore the dependence of
genotype effects on place, time, or stimulus. Interactions were
further explored by pairwise t-tests or by splitting the ANOVA
model, as appropriate. Variables with strongly skewed distributions
or strong correlations between variances and group means were
subjected to Box-Cox transformation before statistical analysis. The
false discovery rate (FDR) control procedure of Hochberg was
applied to groups of conceptually related variables within single
tests to correct significance thresholds for multiple comparisons.
Similarly, FDR correction was applied to t-tests during post hoc test-
ing. Statistical analyses and graphs were produced using R version
3.2.3, complemented with the packages ggplot2, psych, and
moments. All tests were two-sided with significance set at P < 0.05.
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